The Return of Psychedelic Research in America

Mar 11, 2017
The Return of Psychedelic Research in America

Speakers

Anthony Bossis

New York University School Of Medicine

Following decades of dormancy, clinical trials with psychedelics have returned to U.S. medical schools. A key focus evaluates the clinical effects of a psilocybin-generated mystical experience in medical studies. Psilocybin is the hallucinogenic compound found in many species of mushrooms. Subjective features of mystical experience include unity, sacredness, transcendence and a greater connection to positive emotions including love.
Two trials conducted at NYU School of Medicine will be reviewed: The meaning-making effects of psilocybin upon persons with end-of- life existential distress and a study evaluating the effects of psilocybin upon religious leaders. The history of psychedelic research, implications for enhanced well-being, consciousness research, and religious studies will be discussed.

Primary Access: Platinum Badge, Interactive Badge
Secondary Access: Music Badge, Film Badge
Event Type: Session
Track: Health
Level: Advanced